US Map / Colorado
State CO

Clinical Trials in Colorado

Colorado is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Colorado and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 278 actively recruiting studies with Colorado sites out of 278 registered in total. The busiest research areas in Colorado are Advanced Solid Tumor, Breast Cancer, Carcinoma, Non-Small-Cell Lung. Leading sponsors running trials in the state include University of Colorado, Denver, Merck Sharp & Dohme LLC, National Cancer Institute (NCI). By stage, Colorado trials break down as Phase 1 (53), Phase 2 (84), Phase 3 (71), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
278
Recruiting Now
278
← Back to US Map
Top Conditions in Colorado
Advanced Solid Tumor (5)Breast Cancer (4)Carcinoma, Non-Small-Cell Lung (4)Malignant Neoplasm (3)Multiple Myeloma (3)B Acute Lymphoblastic Leukemia (3)Metastatic Breast Cancer (3)Kidney Diseases (3)Pancreatic Ductal Adenocarcinoma (3)Pulmonary Hypertension (3)Alzheimer Disease (3)Type 1 Diabetes (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 278 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 278. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Advanced Solid Tumor, Breast Cancer, Carcinoma, Non-Small-Cell Lung, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT05639907 N/A
Recruiting
Miniscrew Stability and Peri-implant Inflammation When Precoated K21 vs Ethanol ...
Condition
Inflammation Caused by the Placement of a Temporary Anchorage Device
Enrollment
30 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT05780034 Phase 1
Recruiting
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Condition
Relapsed/Refractory B-cell Malignancies
Enrollment
60 pts
Location
United States
Sponsor
Accutar Biotechnology Inc
View Trial →
NCT06415487 Phase 1
Recruiting
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expre...
Condition
Locally Advanced Solid Tumor
Enrollment
30 pts
Location
United States, Taiwan
Sponsor
Acepodia Biotech, Inc.
View Trial →
NCT05735184 Phase 1
Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination ...
Condition
Acute Myeloid Leukemia
Enrollment
420 pts
Location
United States
Sponsor
Kura Oncology, Inc.
View Trial →
NCT06467916 N/A
Recruiting
The Development of PATH, a Program to Support NICU Parent Mental Health Through ...
Condition
Perinatal Mental Health
Enrollment
72 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07194733 N/A
Recruiting
Supporting VETerans With Kidney Disease Through Food As Medicine
Condition
Kidney Diseases
Enrollment
20 pts
Location
United States
Sponsor
VA Eastern Colorado Health Car
View Trial →
NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06680830 Phase 2
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Posi...
Condition
Parkinson Disease
Enrollment
150 pts
Location
United States, Israel, Italy
Sponsor
Neuron23 Inc.
View Trial →
NCT07225751 N/A
Recruiting
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Asses...
Condition
Ankle Arthrodesis or Arthroplasty
Enrollment
126 pts
Location
United States
Sponsor
Kuros Biosurgery AG
View Trial →
NCT06140537 Phase 4
Recruiting
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardio...
Condition
Kidney Transplant; Complications
Enrollment
80 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT04902703 Phase 2
Recruiting
Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheim...
Condition
Alzheimer Disease
Enrollment
42 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT02315729 N/A
Recruiting
Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis
Condition
Adolescent Idiopathic Scoliosis
Enrollment
380 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT04611022 N/A
Recruiting
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Va...
Condition
Human Papilloma Virus
Enrollment
1,000 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07104331 Phase 2
Recruiting
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Sympt...
Condition
Epithelioid Hemangioendothelioma (EHE)
Enrollment
41 pts
Location
United States
Sponsor
Sarcoma Alliance for Research
View Trial →
NCT06941272 Phase 1, Phase 2
Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
50 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07216794 Phase 2
Recruiting
Small Trial of Alendronate Impact on the Reservoir of HIV
Condition
HIV
Enrollment
30 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT06131801 N/A
Recruiting
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solutio...
Condition
Hematologic Malignancy
Enrollment
30 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT07028853 Phase 3
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrom...
Condition
Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
View Trial →
NCT03972657 Phase 1, Phase 2
Recruiting
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone...
Condition
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Enrollment
345 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT05937854 Phase 2
Recruiting
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
Condition
Chronic Obstructive Pulmonary Disease
Enrollment
126 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT07012395 Phase 2
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Seve...
Condition
Ulcerative Colitis
Enrollment
645 pts
Location
United States, Argentina, Australia
Sponsor
Spyre Therapeutics, Inc.
View Trial →
NCT07519772 Phase 1, Phase 2
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Condition
Lymphoma, Non-Hodgkin
Enrollment
280 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07116967 Phase 3
Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants Wit...
Condition
Plaque Psoriasis
Enrollment
3,040 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06701669 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Parid...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
200 pts
Location
United States
Sponsor
PPD Development, LP
View Trial →
NCT06596694 Phase 1, Phase 2
Recruiting
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK...
Condition
Gastrointestinal Cancer
Enrollment
180 pts
Location
United States, Australia, Canada
Sponsor
Merck Sharp & Dohme LLC
View Trial →
Page 6 of 12 — 278 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology